136 related articles for article (PubMed ID: 35079233)
1. Surface mould brachytherapy in oral and oropharyngeal cancers.
Reshko LB; Gaskins JT; Bumpous JM; Tennant PA; Khan Z; Sowards K; Silverman CL; Dunlap NE
Contemp Oncol (Pozn); 2021; 25(4):254-263. PubMed ID: 35079233
[TBL] [Abstract][Full Text] [Related]
2. The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.
Akbaba S; Heusel A; Mock A; Held T; Lang K; Hoerner-Rieber J; Forster T; Katayama S; Kargus S; Rieken S; Plinkert P; Herfarth K; Debus J; Adeberg S
Oral Oncol; 2019 Oct; 97():115-123. PubMed ID: 31494395
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region.
Budrukkar A; Dasgupta A; Pandit P; Laskar SG; Murthy V; Upreti RR; Gupta T; Dholam K; Agarwal JP
J Contemp Brachytherapy; 2017 Jun; 9(3):242-250. PubMed ID: 28725248
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of high dose rate interstitial boost brachytherapy after external beam radiation therapy in head and neck cancer--an Indian (single institutional) learning experience.
Patra NB; Goswami J; Basu S; Chatterjee K; Sarkar SK
Brachytherapy; 2009; 8(2):248-254. PubMed ID: 19230791
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.
Refaat T; Donnelly ED; Gentile M; Novak C; Yuan Y; Khedr GA; Helenowksi I; Lurain J; Schink J; Rademaker A; Sathiaseelan V; Strauss JB; Small W
Am J Clin Oncol; 2016 Apr; 39(2):196-203. PubMed ID: 24487420
[TBL] [Abstract][Full Text] [Related]
7. Squamous Cell and Adenoid Cystic Carcinoma Collision Tumor of the Soft Palate Treated with Surface Mold Brachytherapy.
Reshko L; Khan Z; Sowards KT; Jordan A; Silverman C
Cureus; 2020 Mar; 12(3):e7297. PubMed ID: 32313738
[TBL] [Abstract][Full Text] [Related]
8. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
9. Surface Mould Brachytherapy for Skin Cancers: The British Columbia Cancer Experience.
Casey S; Awotwi-Pratt J; Bahl G
Cureus; 2019 Dec; 11(12):e6412. PubMed ID: 31988814
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy for primary carcinomas of the oral cavity and oropharynx.
Rudoltz MS; Perkins RS; Luthmann RW; Fracke TD; Green TM; Moye L; Wludyka P; Choi YK; Ackerman SN
Laryngoscope; 1999 Dec; 109(12):1967-73. PubMed ID: 10591356
[TBL] [Abstract][Full Text] [Related]
11. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
12. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
[TBL] [Abstract][Full Text] [Related]
13. Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients.
Pialat PM; Mounie M; Podeur F; Gassa F; Suchaud JP; Fleury B; Racadot S; Serre AA; Pommier P
J Contemp Brachytherapy; 2021 Aug; 13(4):402-409. PubMed ID: 34484354
[TBL] [Abstract][Full Text] [Related]
14. Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
Gultekin M; Beduk Esen CS; Balci B; Alanyali S; Akkus Yildirim B; Guler OC; Yuce Sari S; Ergen SA; Sahinler I; Alsan Cetin I; Onal C; Yildiz F; Ozsaran Z
Int J Gynecol Cancer; 2021 Feb; 31(2):185-193. PubMed ID: 32998860
[TBL] [Abstract][Full Text] [Related]
15. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
16. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
[TBL] [Abstract][Full Text] [Related]
17. Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.
Annede P; Gouy S; Mazeron R; Bentivegna E; Maroun P; Petit C; Dumas I; Leary A; Genestie C; Lhommé C; Deutsch E; Morice P; Pautier P; Haie-Meder C; Chargari C
Oncologist; 2017 Feb; 22(2):182-188. PubMed ID: 28174295
[TBL] [Abstract][Full Text] [Related]
18. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications.
Nijdam W; Levendag P; Noever I; Groot CU; Agthoven Mv
Radiother Oncol; 2005 Oct; 77(1):65-72. PubMed ID: 16213619
[TBL] [Abstract][Full Text] [Related]
19. Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Grabenbauer GG; Rödel C; Brunner T; Schulze-Mosgau S; Strnad V; Müller RG; Iro H; Sauer R
Strahlenther Onkol; 2001 Jul; 177(7):338-44. PubMed ID: 11505619
[TBL] [Abstract][Full Text] [Related]
20. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
